 | Sonoma Pharmaceuticals, Inc. | |||
| NCM : SNOA || Location: United States | ||||
$0.16-0.0 (-0.63%) |
0.11 M | 0.15 - 0.17 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.214 M |
| March 28, 2024 | 0.030 M |
| March 15, 2024 | 0.118 M |
| Feb. 29, 2024 | 0.121 M |
| Feb. 15, 2024 | 0.100 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.21 | -0.08 | 62.65% |
| 09/30/2023 | -0.24 | -0.29 | -18.46% |
| 06/30/2020 | 0.00 | 0.54 | 0.00% |
| 03/31/2020 | 0.00 | -0.77 | 0.00% |
| 09/30/2019 | -1.20 | -0.91 | 24.39% |
SNOA Basic Data
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Shares Outstanding | 15.607M | Shares Float | 15.355M |
| Short Float | 0.214M | Market Cap | 2.50M |
| Institution ownership | 1.95% | Insider ownership | 1.557% |
| Earnings Date | 06/19/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.82 | Forward EPS | -0.45 |